Is U.S. Pharmaceuticals FDA approved?

U.S. Pharmaceuticals holds no registered establishment of its own; 22 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does U.S. Pharmaceuticals make?

22 products are listed under U.S. Pharmaceuticals in the openFDA NDC Directory, most often as tablet, film coated; capsule; capsule, liquid filled. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

U.S. Pharmaceuticals

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 22
Live patents: 0
Countries: 0

Catalogue

Drug listings by form and route

22 active NDC listings: 22 human prescription drug. By marketing category: NDA 21, BLA 1.

Dosage form	NDCs
tablet, film coated	13
capsule	2
capsule, liquid filled	2
tablet, extended release	2
injection, solution	1
solution	1
spray	1

Route	NDCs
oral	20
nasal	1
subcutaneous	1

Labeller name on the listing	NDCs
u.s. pharmaceuticals	22

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
BOSULIF	Bosutinib	tablet, film coated, oral	63539-193NDA
CIBINQO	abrocitinib	tablet, film coated, oral	63539-236NDA
CIBINQO	abrocitinib	tablet, film coated, oral	63539-336NDA
CIBINQO	abrocitinib	tablet, film coated, oral	63539-436NDA
Duavee	conjugated estrogens/bazedoxifene	tablet, film coated, oral	63539-122NDA
Elrexfio	elranatamab-bcmm	injection, solution, subcutaneous	63539-252BLA
INLYTA	axitinib	tablet, film coated, oral	63539-026NDA
INLYTA	axitinib	tablet, film coated, oral	63539-044NDA
Ibrance	palbociclib	tablet, film coated, oral	63539-284NDA
Ibrance	palbociclib	tablet, film coated, oral	63539-486NDA
Ibrance	palbociclib	tablet, film coated, oral	63539-688NDA
Litfulo	ritlecitinib	capsule, oral	63539-334NDA
Lorbrena	lorlatinib	tablet, film coated, oral	63539-927NDA
Talzenna	talazoparib	capsule, liquid filled, oral	63539-025NDA
Talzenna	talazoparib	capsule, liquid filled, oral	63539-031NDA
Talzenna	talazoparib	capsule, oral	63539-295NDA
XELJANZ	tofacitinib	tablet, film coated, oral	63539-012NDA
XELJANZ	tofacitinib	tablet, film coated, oral	63539-016NDA
XELJANZ	tofacitinib	solution, oral	63539-029NDA
XELJANZ XR	tofacitinib	tablet, extended release, oral	63539-501NDA
XELJANZ XR	tofacitinib	tablet, extended release, oral	63539-502NDA
ZAVZPRET	zavegepant	spray, nasal	63539-135NDA

Compare

Other companies listing tofacitinib

Zydus Lifesciences Limited12 sites · 717 NDC
Apotex Inc.6 sites · 372 NDC
Micro Labs Limited5 sites · 141 NDC
Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
Golden State Medical Supply Inc.1 site · 670 NDC
Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
AvKARE0 sites · 371 NDC
Pfizer Laboratories Div Pfizer Inc0 sites · 241 NDC
Pfizer Ireland Pharmaceuticals Unlimited Company0 sites · 71 NDC

Enquiry

Common questions

Is U.S. Pharmaceuticals FDA approved?: U.S. Pharmaceuticals holds no registered establishment of its own; 22 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does U.S. Pharmaceuticals make?: 22 products are listed under U.S. Pharmaceuticals in the openFDA NDC Directory, most often as tablet, film coated; capsule; capsule, liquid filled. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.